Abu Dhabi Investment Authority and a group of institutional investors have bought a 7.3 per cent stake in Corona Remedies for ₹777 crore, marking a sizeable secondary market transaction in the Ahmedabad-based drugmaker months after its stock market debut.
The shares changed hands through block deals on the National Stock Exchange, with the transaction executed at ₹1,730 a share. The deal involved about 44.9 lakh shares, with private equity